The Lights and the Shadows of Controlled Sting Challenge With Hymenoptera.
B Ruiz-León, M Martínez San Ireneo, F de la Roca...
https://pubmed.ncbi.nlm.nih.gov/35735250/Actively Recruiting
Led by Inmunotek S.L. · Updated on 2025-05-01
80
Participants Needed
3
Research Sites
13 weeks
Total Duration
This observational clinical follow-up study is designed to evaluate the safety of immunotherapy for treating hymenoptera venom allergy in real-life conditions. It focuses on patients allergic to venom from Apis mellifera bee or Vespula spp. wasp and includes the assessment of both controlled and spontaneous stings. The study is multicentric and will be conducted in Spain with prospective data collection. Participants will receive VENOX immunotherapy, an allergy vaccine targeting venom from wasps or bees, as per clinical recommendations. The study will follow patients for 12 months to monitor safety and tolerability, particularly the incidence of treatment-emergent adverse reactions. It also evaluates treatment effectiveness after reaching a maintenance dose and assesses immunological parameters and quality of life using the SEAIC questionnaire. During the study, participants will be observed over one year with regular follow-ups to collect data on adverse reactions and treatment impact. Researchers will monitor spontaneous natural stings and measure immunological changes. Quality of life related to venom allergy will also be assessed. The total number of participants is expected to be 80, all aged 14 years or older, and of any gender.
CONDITIONS
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
M
Miguel Casanovas
R
Raquel Caballero
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Inmunotek S.L.
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants who undergo routine hymenoptera venom immunotherapy treatment (VENOX) are observed for safety and effectiveness in real-life conditions.
Regular visits as per clinical practice
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
B Ruiz-León, M Martínez San Ireneo, F de la Roca...
https://pubmed.ncbi.nlm.nih.gov/35735250/M T Krishna, P W Ewan, L Diwakar...
https://pubmed.ncbi.nlm.nih.gov/21848758/T Alfaya, A Vega, C Domínguez-Noche...
https://pubmed.ncbi.nlm.nih.gov/26817139/Inmunotek S.L.
Lead Sponsor